Actinium Pharmaceuticals, Inc. quarterly report, Q3 FY2010

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2010, for Cactus Ventures, Inc. (Note: The input metadata referenced "Actinium Pharmaceuticals," but the filing text explicitly identifies the registrant as Cactus Ventures, Inc.). The company is a Nevada corporation classified as a shell company and a smaller reporting company. It has no active operations, no employees, and is currently seeking a business combination or merger with a target entity to become an operating public company.

Key Financial Metrics

MetricPeriod Ended Sep 30, 2010Period Ended Sep 30, 2009
Revenue$0$0
Net Income (Loss)$10,196$(12,834)
Operating Expenses$18,818$8,221
Cash and Cash Equivalents$150$2,122
Total Assets$150$2,122
Total Liabilities$86,246$98,414
Shareholders' Deficit$(86,096)$(96,292)
Working Capital$(86,096)$(96,292)

Debt and Liquidity: The company holds only $150 in cash. Total liabilities include $53,632 in notes payable to related parties, $19,960 in accrued interest, and $12,194 in accounts payable. The company has no lines of credit.

Material Changes vs. Prior Period

  • Net Income Turnaround: The company reported a net income of $10,196 for the nine months ended September 30, 2010, compared to a net loss of $12,834 in the prior year. This reversal was driven entirely by a one-time gain on retention of deposit of $35,000 from an expired Letter of Intent (LOI) with a British Virgin Islands company.
  • Increased Operating Expenses: Operating expenses rose to $18,818 from $8,221 in the prior period, primarily due to an increase in professional fees ($18,170 vs. $7,515).
  • Cash Depletion: Cash on hand decreased by approximately 93% from $2,122 to $150. Net cash used in financing activities was $14,882 due to repayments of related party notes.
  • Liability Reduction: Total liabilities decreased by $12,168, largely due to the repayment of $24,231 in related party notes, partially offset by accrued interest.

Outlook, Risks, and Management Commentary

  • Going Concern: The filing explicitly states that the company's financial position raises substantial doubt about its ability to continue as a going concern. Continuation is dependent on raising additional funds and successfully implementing a business plan (merger/acquisition).
  • Business Plan: The company is a "blank check" entity seeking to merge with a private company to provide it with a public listing. No specific target has been identified, and no negotiations are currently active following the expiration of the February 2010 LOI.
  • Capital Needs: Management anticipates expenses of approximately $20,000 for the next 12 months. The company relies on advances from its president to cover operating costs, with no assurance that such funding will continue.
  • Risks: Significant risks include the inability to locate a suitable merger target, substantial dilution to existing shareholders upon any acquisition, and the lack of a specific business plan or expertise.

Investor Verification Checklist

  • Shell Status: Verify the company has no revenue, no employees, and is solely seeking a reverse merger.
  • Liquidity Crisis: Confirm the extremely low cash balance ($150) against significant liabilities ($86,246) and the reliance on related-party funding.
  • One-Time Gain: Note that the reported net income is non-recurring, derived from a forfeited deposit on a failed transaction.
  • Related Party Debt: Review the $53,632 in notes payable to related parties and the $19,960 in accrued interest.
  • Going Concern Warning: Acknowledge the explicit auditor/management warning regarding the company's ability to continue operations without new capital.